AstraZeneca exec: "We are ready to supply tens of millions of doses" in the U.S.
Millions of doses of the AstraZeneca COVID-19 vaccine are being administered to some of the world's lowest-income countries thanks in part to the global COVAX initiative. The drugmaker plans to request emergency-use authorization for its vaccine from the Food and Drug Administration when the results of its U.S. clinical trial are available in a few weeks. AstraZeneca executive Ruud Dobber spoke with CBSN's Tanya Rivero about the company's vaccination efforts.
UP NEXT
UP NEXT
-
Former President Donald Trump says he's optimistic that the Republican Party will take back Congress in 2022 midterm elections and the White House in 2024
CBS News
-
Remembering the life, legacy of rap superstar DMX
CBS News
-
White House invites bipartisan group of lawmakers to discuss infrastructure plan
CBS News
-
NIH, CDC studying kids hit with long-lasting fatigue, lethargy after COVID diagnosis
CBS News
-
Don’t be the dealer
CBS News
-
Social media platforms struggle with COVID-19 misinformation
CBS News
-
U.S. corporate leaders meet to discuss fighting voter suppression
CBS News
-
Protests erupt in Minnesota after police shooting
CBS News
-
Prince Philip funeral to be held Saturday in Windsor, Queen says his death leaves "huge void"
CBS News
-
Police officer fired for pepper-spraying Black and Latino lieutenant during traffic stop
CBS News
-
Biden to meet with bipartisan group of lawmakers as he pushes $2.3 trillion infrastructure plan
CBS News
-
More than 100 influential U.S. CEOs discuss ways to counter voter restrictions on conference call
CBS News
-
Dr. Ashish Jha discusses concerning COVID surges in Michigan, vaccines
CBS News
-
Protestors clash with police after deadly officer-involved shooting in Minneapolis suburb
CBS News
-
Eye Opener: U.S. administers more than 187 million COVID vaccine doses, CDC says
CBS News
-
"Nomadland" wins 4 BAFTA awards, including best picture
CBS News